These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16855398)

  • 41. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus.
    Ricciardiello L; Baglioni M; Giovannini C; Pariali M; Cenacchi G; Ripalti A; Landini MP; Sawa H; Nagashima K; Frisque RJ; Goel A; Boland CR; Tognon M; Roda E; Bazzoli F
    Cancer Res; 2003 Nov; 63(21):7256-62. PubMed ID: 14612521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of p53 as predictor for the development of esophageal cancer in achalasia patients.
    Leeuwenburgh I; Gerrits MM; Capello A; van den Bogert B; van Dekken H; Steyerberg EW; Siersema PD; Kuipers EJ
    Dis Esophagus; 2010 Aug; 23(6):506-11. PubMed ID: 20113324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
    Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
    Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [APC gene expression in precancerous lesions of stomach examined by light and electron microscopic in situ hybridization].
    Wu H; Yang G; Dong Y
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):308-10. PubMed ID: 11778557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p53 and Ki-67 in Barrett's carcinoma: is there any value to predict recurrence after circumferential endoscopic mucosal resection?
    Lopes CV; Mnif H; Pesenti C; Bories E; Monges G; Giovannini M
    Arq Gastroenterol; 2007; 44(4):304-8. PubMed ID: 18317648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
    Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
    Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.
    Schneider PM; Casson AG; Levin B; Garewal HS; Hoelscher AH; Becker K; Dittler HJ; Cleary KR; Troster M; Siewert JR; Roth JA
    J Thorac Cardiovasc Surg; 1996 Feb; 111(2):323-31; discussion 331-3. PubMed ID: 8583805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.
    Del Portillo A; Lagana SM; Yao Y; Uehara T; Jhala N; Ganguly T; Nagy P; Gutierrez J; Luna A; Abrams J; Liu Y; Brand R; Sepulveda JL; Falk GW; Sepulveda AR
    J Mol Diagn; 2015 Jul; 17(4):412-9. PubMed ID: 26068095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.
    Walch AK; Zitzelsberger HF; Bruch J; Keller G; Angermeier D; Aubele MM; Mueller J; Stein H; Braselmann H; Siewert JR; Höfler H; Werner M
    Am J Pathol; 2000 Feb; 156(2):555-66. PubMed ID: 10666385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
    Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
    Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pathogenetic aspects in precursor lesions of gastrointestinal tumors].
    Rau T
    Pathologe; 2016 Nov; 37(Suppl 2):186-190. PubMed ID: 27638535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.
    Abraham SC; Wu TT; Klimstra DS; Finn LS; Lee JH; Yeo CJ; Cameron JL; Hruban RH
    Am J Pathol; 2001 Nov; 159(5):1619-27. PubMed ID: 11696422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.
    Lomo LC; Blount PL; Sanchez CA; Li X; Galipeau PC; Cowan DS; Ayub K; Rabinovitch PS; Reid BJ; Odze RD
    Am J Surg Pathol; 2006 Apr; 30(4):423-35. PubMed ID: 16625087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the premalignant stages of Barrett's oesophagus through to adenocarcinoma by comparative genomic hybridization.
    Croft J; Parry EM; Jenkins GJ; Doak SH; Baxter JN; Griffiths AP; Brown TH; Parry JM
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1179-86. PubMed ID: 12439111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barrett's oesophagus: mucin composition, neuroendocrine cells, p53 protein, cellular proliferation and differentiation.
    Jaskiewicz K; Louw J; Anichkov N
    Anticancer Res; 1994; 14(5A):1907-12. PubMed ID: 7847825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ
    J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma.
    Rice TW; Goldblum JR; Falk GW; Tubbs RR; Kirby TJ; Casey G
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1132-7. PubMed ID: 7983883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder.
    Wagner U; Sauter G; Moch H; Novotna H; Epper R; Mihatsch MJ; Waldman FM
    Hum Pathol; 1995 Sep; 26(9):970-8. PubMed ID: 7672797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.